Sundry Photography/iStock Editorial via Getty Images
Merck (NYSE:MRK) on Thursday announced plans to invest $895M to expand a manufacturing facility in Kansas, becoming the latest pharma major to boost capital expenditure in the U.S. amid the Trump administration’s tariff threats.
The Rahway, New Jersey-based drugmaker said that